ENLIE Pharmaceutical JSCHSTC:BCP 25 Quick Ratio is 0.00 as of . 20. GuruFocus rates HSTC:BCP with a GF Score™ of 25/100. Among 997 Drug Manufacturers companies, ENLIE Pharmaceutical JSC ranks worse than 100300.8% on this metric.
ENLIE Pharmaceutical JSC has a quick ratio of 0.00. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for ENLIE Pharmaceutical JSC's Quick Ratio or its related term are showing as below:
HSTC:BCP's Quick Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.45 * Ranked among companies with meaningful Quick Ratio only.
ENLIE Pharmaceutical JSC (HSTC:BCP) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
ENLIE Pharmaceutical JSC Quick Ratio Related Terms
ENLIE Pharmaceutical JSC Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ENLIE Pharmaceutical JSC Quick Ratio Chart
ENLIE Pharmaceutical JSC Annual Data
Trend
Quick Ratio
ENLIE Pharmaceutical JSC Semi-Annual Data
Quick Ratio
HSTC:BCP vs : Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, ENLIE Pharmaceutical JSC's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ENLIE Pharmaceutical JSC Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ENLIE Pharmaceutical JSC's Quick Ratio distribution charts can be found below:
* The bar in red indicates where ENLIE Pharmaceutical JSC's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ENLIE Pharmaceutical JSC (HSTC:BCP) has a Quick Ratio of 0.00 as of . 20. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on ENLIE Pharmaceutical JSC and its competitors. According to the industry distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 997 companies in the Drug Manufacturers industry.
Is ENLIE Pharmaceutical JSC's Quick Ratio too high?
ENLIE Pharmaceutical JSC's current Quick Ratio is 0.00. Based on the distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 997 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, ENLIE Pharmaceutical JSC has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENLIE Pharmaceutical JSC's Quick Ratio compare to ?
According to the Drug Manufacturers industry distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 997 companies for Quick Ratio. This places ENLIE Pharmaceutical JSC in the lower half of its industry. The industry median Quick Ratio is 1.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on ENLIE Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ENLIE Pharmaceutical JSC's current Quick Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENLIE Pharmaceutical JSC stock overvalued right now?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a current Quick Ratio of 0.00. The current Quick Ratio is 0.00. ENLIE Pharmaceutical JSC's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For ENLIE Pharmaceutical JSC (HSTC:BCP), the current Quick Ratio is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.
25GF Score
Get the complete analysis for HSTC:BCP
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:BCP has been successfully added to your 